American Healthcare REIT (AHR) affiliate notifies resale of 25,000 shares

Rhea-AI Filing Summary

American Healthcare REIT Inc. affiliate filed a Form 144 reporting a proposed sale of 25,000 shares of Common Stock. The filing lists four restricted‑stock vesting lots (6,651; 6,767; 3,270; 8,312 shares) tied to vesting dates between 10/04/2021 and 10/04/2024, and shows a filing date of 06/26/2026.

Insights

Securities Compliance Counsel

Form 144 notices proposed resale of restricted shares totaling 25,000.

The filing lists four restricted stock vesting lots of 6,651, 6,767, 3,270, and 8,312 shares tied to vesting dates between 10/04/2021 and 10/04/2024. It identifies a broker relationship (Merrill) and a filing date of 06/26/2026.

These notices indicate a holder intends to resell vested restricted shares under the resale procedures for affiliates; actual sale timing and execution method are not shown in the excerpt.

Key Figures

Shares proposed for resale: 25,000 shares Vesting lot 1: 6,651 shares Vesting lot 2: 6,767 shares +3 more

6 metrics

Shares proposed for resale 25,000 shares Total reported on Form 144

Vesting lot 1 6,651 shares Restricted Stock Vesting on 10/04/2021

Vesting lot 2 6,767 shares Restricted Stock Vesting on 04/03/2024

Vesting lot 3 3,270 shares Restricted Stock Vesting on 10/01/2024

Vesting lot 4 8,312 shares Restricted Stock Vesting on 10/04/2024

Form filing date 06/26/2026 Date shown on filing header

Key Terms

Form 144, Restricted Stock Vesting, Merrill

3 terms

Form 144 regulatory

"Filer Information | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Restricted Stock Vesting financial

"Restricted Stock Vesting | American Healthcare REIT Inc"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

Merrill market

"Common | Merrill 8890 Lyra Drive, 5th Floor Columbus OH 43240"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 06/26/2026 - 05:11 PM Accepted by SEC EDGAR 06/26/2026 - 05:11 PM Learn about SEC filing dates

FAQ

What does AHR's Form 144 report?

The Form 144 reports a proposed resale of 25,000 shares of Common Stock by an affiliate. The filing itemizes four restricted‑stock vesting lots totaling these shares and names Merrill as the broker.

How are the 25,000 shares broken down on the filing?

The filing lists four restricted stock vesting lots of 6,651, 6,767, 3,270, and 8,312 shares. These four amounts sum to the reported 25,000 shares scheduled for resale.

Which issuer and broker appear on the Form 144 for AHR?

The issuer named is American Healthcare REIT Inc. and the broker shown is Merrill with an address at 8890 Lyra Drive, 5th Floor, Columbus, OH. The filing ties the resale notice to that broker.

What dates are associated with the securities in the filing?

Vesting dates listed include 10/04/2021, 04/03/2024, 10/01/2024, and 10/04/2024. The Form 144 shows a filing date of 06/26/2026.

Does the Form 144 show the shares were already sold?

The notice lists securities "To Be Sold" and individual vesting lots; it does not show completed sales. The filing reports the proposed resale quantity of 25,000 shares rather than executed transactions.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill 8890 Lyra Drive, 5th Floor Columbus OH 43240	25000	1267403.6	192722308	06/26/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/04/2021	Restricted Stock Vesting	American Healthcare REIT Inc			6651	10/04/2021	NA
Common	04/03/2024	Restricted Stock Vesting	American Healthcare REIT Inc			6767	04/03/2024	NA
Common	10/01/2024	Restricted Stock Vesting	American Healthcare REIT Inc			3270	10/01/2024	NA
Common	10/04/2024	Restricted Stock Vesting	American Healthcare REIT Inc			8312	10/04/2024	NA

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)